NasdaqCM - Nasdaq Real Time Price USD
Cyclacel Pharmaceuticals, Inc. (CYCC)
2.0000
-0.2000
(-9.09%)
At close: May 16 at 4:00:02 PM EDT
2.1000
+0.10
+(5.00%)
After hours: May 16 at 7:30:46 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 196,016,980 | 32 |
| Sales | 194,628,832 | 2 |
| Net Shares Purchased (Sold) | 1,388,148 | 34 |
| Total Insider Shares Held | 233.76M | -- |
| % Net Shares Purchased (Sold) | 0.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LAZAR DAVID ELLIOT Chief Executive Officer | Sale at price 0.03 per share. | Direct | 5,507,996 | Feb 26, 2025 |
| LAZAR DAVID ELLIOT Chief Executive Officer | -- | Direct | -- | Feb 26, 2025 |
| NATAN DAVID Director | -- | Direct | -- | Jan 2, 2025 |
| SCHWARTZ BRIAN Officer and Director | -- | Direct | -- | Jan 29, 2024 |
| ROMBOTIS SPIRO GEORGE Chief Executive Officer | Purchase at price 3.32 per share. | Direct | 20,122 | Dec 21, 2023 |
| MCBARRON PAUL Chief Operating Officer | Purchase at price 3.32 per share. | Direct | 6,252 | Dec 21, 2023 |
| BARKER SAMUEL L Director | -- | Direct | -- | Jun 30, 2023 |
| HENNEY CHRISTOPHER S Director | -- | Direct | -- | Jun 30, 2023 |
| WALKER KARIN LORRAINE Director | -- | Direct | -- | Jun 30, 2023 |
| SCHWARTZ BRIAN Director | -- | Direct | -- | Jun 30, 2023 |
| SPIEGEL ROBERT J Director | -- | Direct | -- | Jun 30, 2023 |
| FERGUSON KENNETH M Director | -- | Direct | -- | Jun 30, 2023 |
Related Tickers
ALZN Alzamend Neuro, Inc.
3.4000
+3.34%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
CDIO Cardio Diagnostics Holdings, Inc.
3.8400
-4.00%
ONCO Onconetix, Inc.
0.0847
+13.54%
RNAZ TransCode Therapeutics, Inc.
8.16
+6.67%
MLEC Moolec Science SA
8.86
+8.06%
ABP Abpro Corporation
0.2300
-13.24%
VOR Vor Biopharma Inc.
0.1769
+3.51%
QNRX Quoin Pharmaceuticals, Ltd.
7.70
0.00%
NCNA NuCana plc
0.0438
-17.98%